Humana Inc (NYSE: HUM) kicked off on Monday, down -1.98% from the previous trading day, before settling in for the closing price of $260.71. Over the past 52 weeks, HUM has traded in a range of $213.31-$527.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 13.38%. While this was happening, its average annual earnings per share was recorded -38.15%. With a float of $120.11 million, this company’s outstanding shares have now reached $122.22 million.
Considering the fact that the conglomerate employs 67600 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 88.39%, operating margin of 2.28%, and the pretax margin is 1.73%.
Humana Inc (HUM) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Healthcare Plans Industry. The insider ownership of Humana Inc is 0.25%, while institutional ownership is 95.65%. The most recent insider transaction that took place on Feb 20 ’24, was worth 200,066. In this transaction Director of this company bought 545 shares at a rate of $367.09, taking the stock ownership to the 2,578 shares.
Humana Inc (HUM) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.11 earnings per share (EPS), lower than consensus estimate (set at 0.15) by -0.26. Wall Street market experts anticipate that the next fiscal year will bring earnings of 7.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -38.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.00% during the next five years compared to 10.46% growth over the previous five years of trading.
Humana Inc (NYSE: HUM) Trading Performance Indicators
Take a look at Humana Inc’s (HUM) current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 11.29, a number that is poised to hit -2.00 in the next quarter and is forecasted to reach 17.62 in one year’s time.
Technical Analysis of Humana Inc (HUM)
Compared to the last year’s volume of 1.86 million, its volume of 2.07 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 18.00%. Additionally, its Average True Range was 10.80.
During the past 100 days, Humana Inc’s (HUM) raw stochastic average was set at 21.87%, which indicates a significant decrease from 29.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.47% in the past 14 days, which was lower than the 42.80% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $295.09, while its 200-day Moving Average is $338.78. Nevertheless, the first resistance level for the watch stands at $261.15 in the near term. At $266.75, the stock is likely to face the second major resistance level. The third major resistance level sits at $271.41. If the price goes on to break the first support level at $250.89, it is likely to go to the next support level at $246.23. Now, if the price goes above the second support level, the third support stands at $240.63.
Humana Inc (NYSE: HUM) Key Stats
The company with the Market Capitalisation of 31.11 billion has total of 120,411K Shares Outstanding. Its annual sales at the moment are 106,374 M in contrast with the sum of 2,489 M annual income. Company’s last quarter sales were recorded 29,540 M and last quarter income was 679,000 K.
